LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing <i>LOXL2</i>-induced epithelial-mesenchymal transition (EMT)-Reference-Cited by-同舟云学术

LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT)

Published:2022-05-11 Issue:17 Volume:21 Page:1827-1841
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Peng Ting¹²,Lin Shitong¹²,Meng Yifan³,Gao Peipei¹²,Wu Ping¹²,Zhi Wenhua¹²,Ding Wencheng¹²,Cao Canhui¹⁴,Wu Peng¹²

Affiliation:

1. Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

2. Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

3. Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

4. Department of Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China

Funder

National Natural Science Foundation of China

The China Postdoctoral Science Foundation

Shenzhen Science and Technology Innovation Commitiontee

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2022.2073047

Reference57 articles.